HILLSBOROUGH, N.J., April 1, 2008 /PRNewswire-USNewswire/ -- The
Melanoma Research Foundation (MRF) recently approved 2008 grants through
the MRF Research Grant Program totaling more than $1 million, providing a
substantial boost to the melanoma research community. This initiative
supports promising medical research that furthers the goal of developing an
effective treatment and possible cure of malignant melanoma, while
encouraging scientists and clinicians to join in this mission.
"We are particularly excited about these grants as they support young
scientists with a dream for finding a cure and experienced scientists with
a vision for the future of cancer research," said Randy Lomax, Chairman,
Board of Directors, Melanoma Research Foundation. "This funding represents
our strong and ongoing commitment to support medical research for
The newly awarded grants were provided as part of the MRF's Career
Development Grant Program and Established Investigator Grant Program. The
Career Development Grant provides funding of up to $50,000 per year for two
years to investigators who are beginning a research career emphasizing
melanoma-related projects. The Established Investigator Grant provides
funding of up to $100,000 per year for two years to established researchers
in melanoma or those in closely related fields who wish to move into
These grants, awarded through a scientific peer-review system paneled
by leading clinical and basic melanoma researchers, are made possible by
charitable donations in support of innovative melanoma research. In fact,
two of the grants recently provided were awarded in the names of Danny
Federici -- keyboardist for Bruce Springsteen and the E Street Band and
melanoma patient -- and the late James Robbins -- former president and
chief executive officer of COX Communications -- respectively, for their
generous donations to the MRF. The recipients include:
Career Development Grants:
-- Dr. Paul Antony, University of Maryland -- Baltimore, "Inducing
Potent Anti-Tumor Immunity Against Melanoma Using Cytokine/Antibody Immune
-- Dr. Susanne Schlisio, Dana-Farber Cancer Institute, "Neuronal
Apoptosis by the Prolyl Hydroxylase EglN3: Oxygen Sensing and Cancer"
-- Dr. Soheil Dadras, Stanford University, "The Role of Small
Ribonucleic Acids in the Progression of Cutaneous Melanoma"
-- Dr. Karen Taraszka Hastings, University of Arizona, "Role of
Lysosomal Thiolreductase GILT in Activation of Melanoma-Specific T
-- Dr. William Kim, University of North Carolina at Chapel Hill,
"Interrogating the Role of HIF in Malignant Melanoma"
-- Dr. Jedd Wolchok, Memorial Sloan-Kettering Cancer Center, "Particle
Mediated Epidermal Delivery of Xenogeneic gp100 DNA Vaccines for Melanoma"
(The grant awarded to Dr. Wolchok was designated and funded by the
Established Investigator Grants:
-- Dr. Edward DeFabo, George Washington University, "Mechanisms of UVB
Initiation of Melanoma: A Novel in Vivo Approach"
-- Dr. Boris C Bastian, University of California -- San Francisco,
"Integrating Genetic and Morphologic Features of Melanoma to Improve
-- Dr. Patrick Hwu, MD Anderson Cancer Center, "Regulatory Immune Cell
Interactions in the Microenvironment of Melanoma Metastases"
"We continue to rely on the generosity of others to help fund
innovative research to further the goal of developing effective treatments
and ultimately a cure for melanoma," said Linda Pilkington, Executive
Director, Melanoma Research Foundation. "In 2008, the MRF looks forward to
providing crucial funding to help bridge the gap in melanoma research to
ensure that patients of tomorrow have the help they need."
Melanoma, the most serious type of skin cancer, is one of the fastest
growing cancers in the U.S., and can strike people of all ages, all races
and both sexes. One in 50 people have a lifetime risk of developing
melanoma. In fact, in 2008, more than 62,000 Americans are expected to be
diagnosed with invasive melanoma, resulting in an estimated 8,400 deaths.
Until there is a cure for melanoma, research is crucial to ensure patients
of tomorrow have the help and hope they deserve.
To learn more about donating to MRF and its research programs, please
About the Melanoma Research Foundation
The Melanoma Research Foundation is the largest private, national
organization devoted to melanoma in the United States. The Foundation is
committed to the support of medical research in finding effective
treatments and eventually a cure for melanoma. The Foundation also educates
patients and physicians about prevention, diagnosis and treatment of
melanoma, while acting as an advocate for the melanoma community to raise
awareness of this disease and the need for a cure. The MRF Web site is the
premiere source for melanoma information seekers. More information is
available at http://www.melanoma.org.
SOURCE Melanoma Research Foundation